D
Relmada Therapeutics, Inc. RLMD
$0.627 $0.0172.79% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 7.40M 6.27M 8.08M 11.86M 8.10M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 10.22M 18.22M 19.08M 23.01M 18.82M
Operating Income -10.22M -18.22M -19.08M -23.01M -18.82M
Income Before Tax -9.87M -17.56M -18.66M -21.73M -17.77M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -9.87M -17.56M -18.66M -21.73M -17.77M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -9.87M -17.56M -18.66M -21.73M -17.77M
EBIT -10.22M -18.22M -19.08M -23.01M -18.82M
EBITDA -- -- -- -- --
EPS Basic -0.30 -0.58 -0.62 -0.72 -0.59
Normalized Basic EPS -0.19 -0.37 -0.38 -0.46 -0.37
EPS Diluted -0.30 -0.58 -0.62 -0.72 -0.59
Normalized Diluted EPS -0.19 -0.37 -0.38 -0.46 -0.37
Average Basic Shares Outstanding 33.19M 30.41M 30.17M 30.17M 30.17M
Average Diluted Shares Outstanding 33.19M 30.41M 30.17M 30.17M 30.17M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --